1. Recent advances in cellular therapy for malignant lymphoma
   Junji Tanaka, 2021, Cytotherapy CrossRef
2. Efficacy of cascade-primed cell infusion as an adjuvant immunotherapy with concurrent chemotherapy for patients with non–small-cell lung cancer: A retrospective observational study with a 5-year follow-up
   Hong Li et al, 2020, Cytotherapy CrossRef
3. Immune checkpoint inhibitors and cellular treatment for lymphoma immunotherapy
   F Li et al, 2021, Clinical and Experimental Immunology CrossRef
4. Dendritic cell/cytokine‐induced killer cell‐based immunotherapy in lung cancer: What we know and future landscape
   Monireh Mohsenzadegan et al, 2020, Journal of Cellular Physiology CrossRef
5. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells
   Anna Dalla Pietà et al, 2021, Journal for ImmunoTherapy of Cancer CrossRef
6. Adenovirus co-expressing CD40 ligand and interleukin (IL)-2 contributes to maturation of dendritic cells and production of IL-12
   Zhi Guo et al, 2016, Biomedical Reports CrossRef
7. Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials
   Ying Zhang et al, 2021, Cancers CrossRef